HeartSciences (HSCS) Return on Equity (2022 - 2026)

HeartSciences (HSCS) has 5 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Jan 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.02%, down from 0.02% in the prior quarter.
• Across five years, Return on Equity topped out at 4.62% in Q2 2023 and bottomed at 0.16% in Q1 2023.
• The 5-year median for Return on Equity is 0.02% (2024), against an average of 0.29%.
• The widest annual swing landed in 2023, when Return on Equity surged 461 bps; it then plunged 463 bps in 2024.
• A 5-year view of Return on Equity shows it stood at 0.03% in 2022, then jumped by 266 bps to 0.06% in 2023, then slumped by 128 bps to 0.02% in 2024, then slumped by 59 bps to 0.02% in 2025, then decreased by 1 bps to 0.02% in 2026.
• The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.

Peer Comparison